News

StemCells, a clinical-stage biotechnology company, has granted a non-exclusive license for the company’s recently acquired internal ribosome entry site technology to a major international pharmaceutical company. According to

Under the terms of the agreement, Galapagos will receive an upfront fee of E2.5 million from Merck. In addition, Galapagos is eligible to receive discovery, development and regulatory

The gross proceeds to Hansen Medical, before expenses, from the sale of shares are expected to be $37.99 million. The closing of the offering is expected to take

Norway-based pharmaceutical company Clavis Pharma has initiated the first Phase II study with Intravenous CP-4126 in patients with newly diagnosed, advanced pancreatic cancer. Intravenous CP-4126 is a novel

Ms Mahony joined Lilly more than eight years ago, after more than a decade in sales and marketing roles in the UK and Europe for Amgen, Bristol-Myers Squibb

Galea Life Sciences, a developer of therapeutic functional food products and dietary supplements, has reported that its proprietary Nutraplete therapeutic drink mix, has received approval for Medicaid reimbursement

According to Covidien, the alarm management system enhances the information provided by traditional pulse oximeters and supports efficient, comprehensive care of patients who are at risk for upper

Mr Doughty and Mr Kraus will assume responsibilities previously performed by John Borrell, who has left the company to pursue other opportunities. Additionally, the company announced that Nabil

According to ATS Medical, the ATS AP360 heart valve maximizes hemodynamic performance with a new supra-annular cuff design that facilitates implantation. The original ATS Medical Open Pivot heart